| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA700292 | F | Inhibition of growth of IMR 32 human tumor cell line | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 2. | ALA700295 | F | Ability to stimulate Rb+ efflux from human IMR-32 cell preparations containing human alpha3-betaX receptors | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
| 3. | ALA700296 | F | Cholinergic interactions was measured with FLIPR device on IMR-32 cells of human neuroblastoma clonal line, given as effective dose | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 4. | ALA700122 | F | Concentration required to elicit ganglionic receptors measured using [86Rb+] flux functional assay in a human neuroblastoma-derived IMR-32 cell line | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 5. | ALA700123 | F | Concentration required to elicit ganglionic receptors measured using [86Rb+] flux functional assay in a human neuroblastoma-derived IMR-32 cell line; Not tested | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 6. | ALA877917 | F | Effective dose to protect IMR-32 cells from beta-Amyloid (BA) insult was determined using MTT reduction assay | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
| 7. | ALA700124 | F | Ability to stimulate Rb+ efflux from human IMR-32 cell preparations containing human alpha3-betaX receptors | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 8. | ALA700009 | F | Antitumor activity was evaluated against human neuroblastoma cell line IMR-32. | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
| 9. | ALA700010 | F | In vitro cytotoxicity against human cancerous neuroblastoma cells (IMR-32) | Homo sapiens | 23 | cell-based format | Scientific Literature | ||
| 10. | ALA700011 | F | Cholinergic interactions was measured with FLIPR device on cells of IMR-32 human neuroblastoma clonal line and given as Intrinsic activity | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 11. | ALA700670 | F | Maximum efficacy relative to 100(uM) (S)-nicotine for cell preparations containing alpha3-betaX IMR32 cells | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
| 12. | ALA700671 | F | The maximal efficacy relative to 100 uM nicotine | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 13. | ALA879041 | F | The maximal efficacy relative to 100 uM nicotine; Not tested | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 14. | ALA700672 | F | Maximal response of compound at 10 uM concentration in an in vitro [86Rb+] release assay using IMR-32 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 15. | ALA700673 | F | Maximal response of compound at 1 uM concentration in an in vitro [86Rb+] release assay using IMR-32 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 16. | ALA700674 | F | Maximal response of compound at concentration 3 uM concentration in an in vitro [86Rb+] release assay using IMR-32 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 17. | ALA700675 | F | Maximal response of compound was determined in an in vitro [86Rb+] release assay using IMR-32 cells | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 18. | ALA700676 | F | Cholinergic interactions was measured with FLIPR device on cells of IMR-32 human neuroblastoma clonal line and given as Intrinsic activity | Mus musculus | 1 | cell-based format | Scientific Literature | ||
| 19. | ALA700677 | F | Evaluated in vitro for the inhibition of Adenosine (ADO) phosphorylation in intact cells. | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 20. | ALA700678 | F | Antitumor activity against human neuroblastoma IMR32 cells | Homo sapiens | 3 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!